dc.contributor.author |
Greil, Richard |
dc.contributor.author |
Tedeschi, Alessandra |
dc.contributor.author |
Moreno, Carol |
dc.contributor.author |
Anz, Bertrand |
dc.contributor.author |
Larratt, Loree |
dc.contributor.author |
Simkovic, Martin |
dc.contributor.author |
Gill, Devinder |
dc.contributor.author |
Gribben, John G. |
dc.contributor.author |
Flinn, Ian W. |
dc.contributor.author |
Wang, Zhengyuan |
dc.contributor.author |
Cheung, Leo W. K. |
dc.contributor.author |
Nguyen, Aaron N. |
dc.contributor.author |
Zhou, Cathy |
dc.contributor.author |
Styles, Lori |
dc.contributor.author |
Demirkan, Fatih |
dc.contributor.author |
Universitat Autònoma de Barcelona |
dc.date |
2021 |
dc.identifier |
https://ddd.uab.cat/record/245163 |
dc.identifier |
urn:10.1007/s00277-021-04536-6 |
dc.identifier |
urn:oai:ddd.uab.cat:245163 |
dc.identifier |
urn:pmcid:PMC8195966 |
dc.identifier |
urn:pmc-uid:8195966 |
dc.identifier |
urn:pmid:34018029 |
dc.identifier |
urn:articleid:14320584v100p1733 |
dc.identifier |
urn:oai:pubmedcentral.nih.gov:8195966 |
dc.format |
application/pdf |
dc.language |
eng |
dc.publisher |
|
dc.relation |
Annals of Hematology ; Vol. 100 (may 2021), p. 1733-1742 |
dc.rights |
open access |
dc.rights |
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
dc.rights |
https://creativecommons.org/licenses/by/4.0/ |
dc.subject |
Infusion-related reactions |
dc.subject |
Ibrutinib |
dc.subject |
Obinutuzumab |
dc.subject |
Cytokines |
dc.title |
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL : analysis from the iLLUMINATE study |
dc.type |
Article |
dc.description.abstract |
The online version contains supplementary material available at 10.1007/s00277-021-04536-6. |